Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-09-26 pm EDT
119.69 USD   -3.19%
05:20pU.S. FDA clears additional lots of Moderna's Covid booster amid shortage
RE
11:43aEMA's CHMP Starts Evaluating Application For Authorisation Of Additional Adapted Version Of Spikevax
RE
07:20aPfizer/BioNTech seek FDA nod for new COVID boosters for children
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Morgan Stanley Adjusts Moderna's Price Target to $197 From $199, Maintains Equalweight Rating

08/04/2022 | 11:06am EDT


© MT Newswires 2022
All news about MODERNA, INC.
05:20pU.S. FDA clears additional lots of Moderna's Covid booster amid shortage
RE
11:43aEMA's CHMP Starts Evaluating Application For Authorisation Of Additional Adapted Versio..
RE
07:20aPfizer/BioNTech seek FDA nod for new COVID boosters for children
RE
07:07aInsider Sell: Moderna
MT
01:26aValneva in talks with potential partner on second-gen COVID-19 vaccines
RE
09/23Insider Sell: Moderna
MT
09/23Healthcare Shares Slip But Perform Better Than Broader Market -- Healthcare Roundup
DJ
09/23U.S. rollout of new COVID boosters off to slow start
RE
09/23Over 4 million Americans administered updated COVID boosters, says CDC
RE
09/22Carisma and Sesen Bio Combine, Raise $30M for CAR-M Therapeutics
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 889 M - -
Net income 2022 10 978 M - -
Net cash 2022 15 984 M - -
P/E ratio 2022 4,70x
Yield 2022 -
Capitalization 48 368 M 48 368 M -
EV / Sales 2022 1,48x
EV / Sales 2023 2,80x
Nbr of Employees 2 700
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 123,64 $
Average target price 214,75 $
Spread / Average Target 73,7%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-51.32%48 368
IQVIA HOLDINGS INC.-32.86%35 330
LONZA GROUP AG-41.68%33 599
SEAGEN INC.-9.96%25 673
ALNYLAM PHARMACEUTICALS, INC.18.40%24 099
CELLTRION, INC.-16.92%16 277